HEALTH PROFESSIONAL · SOURCE READING
Postoperative radiation therapy
Source: Childhood Soft Tissue Sarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: April 21, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment Option Overview for Childhood Soft Tissue Sarcoma / Radiation Therapy
Radiation therapy can also be given postoperatively. In general, radiation is indicated for patients with inadequate surgical margins and for larger, high-grade tumors.[32,33] This is particularly important in high-grade tumors with tumor margins smaller than 1 cm.[34,35]; [36][Level of evidence C3] With combined R0 (negative margin) surgery and radiation therapy, local control of the primary tumor can be achieved in about 90% of patients with extremity sarcomas, 70% to 75% of patients with retroperitoneal sarcomas, and 80% of patients overall.[21,37-40]
Retroperitoneal sarcomas are unique in that the radiosensitivity of the bowel increases the risk of injury and makes postoperative radiation therapy less desirable.[41,42] Postoperative adhesions and bowel immobility can increase the risk of damage from any given radiation dose. This contrasts with the preoperative approach in which the tumor often displaces bowel outside of the radiation field, and any exposed bowel is more mobile, which decreases exposure to specific bowel segments.
Publication references
Read the original reference and check its publication notices.
- PubMed 10359161 · Original source
- PubMed 10561182 · Original source
- PubMed 10661350 · Original source
- PubMed 10862210 · Original source
- PubMed 17394945 · Original source
- PubMed 18234441 · Original source
- PubMed 26068493 · Original source
- PubMed 26130233 · Original source
- PubMed 26916507 · Original source
- PubMed 9386667 · Original source
Preserved source evidence · Not medical advice
Triangle